I
MiNK Therapeutics D
D
INKT
7.40000
USD
0.28
(3.93%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
29,493,862
العنوان: MiNK Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.